India's Pharmaceutical Exports

Country Profile

Israel

Israel is a growing market for Indian pharmaceuticals — $58.5M in FY 2025–26. Medicine Ingredients accounts for 56% of shipments, with vaccines contributing $2.64M.

🇮🇱 $58.5M · 0.7× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$58.5M
Exports FY2025–26 DGCIS
0.7×
Growth FY2015→2026
56%
Medicine Ingredients Share
5
Product Categories Supplied
12
Years of Trade Data
Israel is a growing market for Indian pharmaceuticals — $58.5M in FY 2025–26. Medicine Ingredients accounts for 56% of shipments, with vaccines contributing $2.64M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $32.6M (55.8%) Medicines $16.4M (28.1%) Surgical & Hospital Supplies $5.83M (10.0%) Vaccines $2.64M (4.5%) Traditional & Herbal $974K (1.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Israel in the RBI overseas direct investment dataset (2011–2026).